---
created: 2025-04-13
updated: 2025-04-13T10:51
id: c&$b/_Jvc&
specialty: cardio
specialty_id: 283
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - source/ak-step1-v11::
  - theme/firstaid::07-cardiovascular::05-pharm::03-calcium-channel-blockers
  - source/ak-step1-v11::
  - source/ome-banner::basic-science::09-cardiac
  - source/ak-step1-v11::
  - theme/physeo::09-pharm::10-cardiac::01-hypertension-treatment
  - source/ak-step1-v11::
  - theme/physeo::09-pharm::10-cardiac::02-calcium-channel-blockers
  - source/ak-step1-v11::
  - theme/physeo::09-pharm::10-cardiac::20-class-iv-antiarrhythmics
  - source/ak-step1-v11::
  - theme/sketchypharm::02-cardio-&-renal::03-antihypertensives::01-calcium-channel-blockers
  - source/ak-step1-v11::^other::^highyield::2-relativelyhighyield
  - source/ak-step1-v11::^systems::cardio::pharmacology
  - source/ak-step2-v11::
  - theme/b&b::01-cardiology::pharm::cvs-pharm-1"
type: flashcard
---

# Question
**Non-dihydropyridine** CCBs may cause excessive AV block when combined with **Î²**-adrenergic antagonists

---

# Answer
non-DHP CCBs (ie, diltiazem, verapamil) + beta-blockers == decrease in HR == AV block